Casey Woodring
Stock Analyst at JP Morgan
(0.40)
# 4,163
Out of 4,984 analysts
34
Total ratings
20%
Success rate
-19.36%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $145 → $160 | $152.72 | +4.77% | 8 | Aug 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $175.21 | -14.39% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $28.73 | -12.98% | 4 | Apr 21, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $68.20 | +37.83% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $45.42 | +22.46% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.29 | +82.37% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $20.49 | +12.25% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $16.25 | +10.77% | 2 | Jan 23, 2023 |
Charles River Laboratories International
Aug 7, 2025
Maintains: Neutral
Price Target: $145 → $160
Current: $152.72
Upside: +4.77%
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $175.21
Upside: -14.39%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $28.73
Upside: -12.98%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $68.20
Upside: +37.83%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $45.42
Upside: +22.46%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.29
Upside: +82.37%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $20.49
Upside: +12.25%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $16.25
Upside: +10.77%